We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAB icon
2976
AnaptysBio
ANAB
$1.58B
$1.09M ﹤0.01%
67,091
+45,638
+213% +$1.08M
AMCR icon
2977
PUT
Amcor
AMCR
$20.8B
$1.08M ﹤0.01%
+19,980
New +$1M
KBWY icon
2978
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$313M
$1.08M ﹤0.01%
34,683
+2,936
+9% +$91K
LTHM
2979
DELISTED
Livent Corporation
LTHM
$1.08M ﹤0.01%
126,064
-66,908
-35% -$512K
MATW icon
2980
Matthews International
MATW
$866M
$1.08M ﹤0.01%
28,216
+3,681
+15% +$135K
TUR icon
2981
iShares MSCI Turkey ETF
TUR
$200M
$1.08M ﹤0.01%
39,754
+5,987
+18% +$155K
LGF.A
2982
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$1.08M ﹤0.01%
100,946
+27,858
+38% +$257K
HACK icon
2983
Amplify Cybersecurity ETF
HACK
$2.68B
$1.08M ﹤0.01%
25,923
+10,035
+63% +$401K
WRLD icon
2984
World Acceptance Corp
WRLD
$838M
$1.07M ﹤0.01%
12,441
+4,911
+65% +$506K
AORT icon
2985
Artivion
AORT
$1.3B
$1.07M ﹤0.01%
39,612
-5,530
-12% -$136K
CF icon
2986
CALL
CF Industries
CF
$19.2B
$1.07M ﹤0.01%
+22,500
New +$1.05M
KAI icon
2987
Kadant
KAI
$3.63B
$1.07M ﹤0.01%
10,155
-2,029
-17% -$193K
HFWA icon
2988
Heritage Financial
HFWA
$1.22B
$1.07M ﹤0.01%
37,762
-1,456
-4% -$40.2K
CCXI
2989
DELISTED
ChemoCentryx, Inc.
CCXI
$1.07M ﹤0.01%
27,043
+9,393
+53% +$165K
HL icon
2990
Hecla Mining
HL
$9.47B
$1.06M ﹤0.01%
313,947
-4,801
-2% -$11.8K
STSA
2991
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$1.06M ﹤0.01%
53,970
-254,614
-83% -$3.62M
SKIL icon
2992
Skillsoft
SKIL
$63.7M
$1.06M ﹤0.01%
+5,139
New +$1.05M
ADVM
2993
DELISTED
Adverum Biotechnologies
ADVM
$1.06M ﹤0.01%
9,195
+7,975
+654% +$703K
OXM icon
2994
Oxford Industries
OXM
$566M
$1.06M ﹤0.01%
13,989
+303
+2% +$21.9K
ZG icon
2995
Zillow
ZG
$7.94B
$1.05M ﹤0.01%
23,008
-6,506
-22% -$241K
FBNC icon
2996
First Bancorp
FBNC
$2.6B
$1.05M ﹤0.01%
26,296
+2,522
+11% +$96.6K
TIMB icon
2997
TIM SA
TIMB
$9.16B
$1.05M ﹤0.01%
54,838
+10,971
+25% +$173K
NTUS
2998
DELISTED
Natus Medical Inc
NTUS
$1.05M ﹤0.01%
31,780
+1,300
+4% +$41.7K
AKS
2999
DELISTED
AK Steel Holding Corp
AKS
$1.05M ﹤0.01%
318,521
+40,359
+15% +$112K
CTMX icon
3000
CytomX Therapeutics
CTMX
$675M
$1.04M ﹤0.01%
125,761
+36,191
+40% +$244K

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.